Infectious Disease

The hepatitis C vaccine could be ready in 5 years, says Nobel Laureate

Source / information

Source:

Houghton M. et al. Summary 2660. Closing the loop: a vaccine against HCV. Presented at ECCMID; 9-12 July 2021 (virtual meeting).

Disclosure:
Healio was unable to confirm any relevant financial information for Houghton at the time of publication.

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

Sir Michael Houghton, who won a Nobel Prize last year for his contribution to the discovery of the hepatitis C virus, recently said during a presentation at the ECCMID virtual meeting that an HCV vaccine could be ready within 5 years.

Globally, there are up to 2 million new HCV cases and around 400,000 deaths from the virus annually, according to ECCMID. In addition, most of the 7 million people who carry HCV go undiagnosed.

Source: Shutterstock.com.

“While the advent of direct acting antivirals to cure hepatitis C has given us a formidable weapon to turn the tide on this pandemic, there is no doubt that a vaccine is needed to help the world achieve its ambitious goal reach new hepatitis C infections by 90% and the death rate by 2030 by 65%, “said Houghton, who shared the 2020 Nobel Prize in Medicine with two other scientists, in a press release.

Houghton and colleagues at the University of Alberta’s Li Ka Shing Institute of Applied Virology are developing an adjuvanted recombinant vaccine that he believes could be introduced to immunize people who inject drugs by 2026 or 2027, if it proves safe and effective proves.

“According to Phase 3 studies, the hepatitis C vaccine could then be rolled out to other high-risk groups, such as men who have sex with men, health workers and babies born to mothers with hepatitis C countries around the world, from or around 2029 “Said Houghton.

He said the vaccine could save nearly a billion dollars compared to the cost of treatment.

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact customerservice@slackinc.com.

Back to Healio

European Congress for Clinical Microbiology and Infectious Diseases

European Congress for Clinical Microbiology and Infectious Diseases

Related Articles